Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: ascorbyl palmitate; water for injections; sodium oleate; sodium hydroxide; glycerol; egg lecithin - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil; olive oil - injection, intravenous infusion - excipient ingredients: egg lecithin; ascorbyl palmitate; glycerol; water for injections; sodium hydroxide; sodium oleate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 20.76 g; olive oil, quantity: 17.3 g; medium chain triglycerides, quantity: 17.3 g; fish oil - rich in omega-3 acids, quantity: 13.84 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 16.38 g; olive oil, quantity: 13.65 g; medium chain triglycerides, quantity: 13.65 g; fish oil - rich in omega-3 acids, quantity: 10.92 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil, quantity: 12.36 g; olive oil, quantity: 10.3 g; medium chain triglycerides, quantity: 10.3 g; fish oil - rich in omega-3 acids, quantity: 8.24 g - injection, emulsion - excipient ingredients: egg lecithin; glycerol; sodium oleate; dl-alpha-tocopherol; sodium hydroxide; water for injections - finomel is indicated for parenteral nutrition in adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Kenya - English - Pharmacy and Poisons Board

aculife healthcare pvt ltd commerce house-v, besides vodafone house, prahlad - intravenous fat emulsion (20%w/v) (soyabean oil… - infusion - each 100 ml contains soyabean oil usp 20.0 gm egg… - intravenous solutions: solutions for parenteral

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: water for injections; glycerol; soya oil; medium chain triglycerides; sodium oleate; egg lecithin; sodium hydroxide - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 500 mg - injection, emulsion - excipient ingredients: glycerol; soya oil; sodium hydroxide; medium chain triglycerides; water for injections; egg lecithin; sodium oleate - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 200 mg - injection, emulsion - excipient ingredients: medium chain triglycerides; sodium oleate; glycerol; sodium hydroxide; water for injections; egg lecithin; soya oil - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive mct-lct 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. provive mct-lct 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive mct-lct 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - propofol, quantity: 1000 mg - injection, emulsion - excipient ingredients: egg lecithin; soya oil; sodium oleate; water for injections; sodium hydroxide; glycerol - short acting intravenous anaesthetic agent suitable for induction and maintenance of general anaesthesia in adults and children aged three years and older. provive 1% has no analgesic properties. although the safety and efficacy of propofol in paediatric day surgery have not been demonstrated, it may also be a useful agent in this setting and its use should not be precluded. provive 1% may also be used in adults for sedation of ventilated patients receiving intensive care. provive 1% may also be used in adults for monitored conscious sedation and diagnostic procedures.